RVTY

NYSE

REVVITY, INC.

Health Care, Health Care Equipment

$114.66

close 7 Aug 2026

+33.64%

52-week change

$12.80B

market cap

$81.22

$118.30

52-week range

Expected price

$52.60 – $64.29

Current price

$114.66

Signal

Could be overvalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)55.13x

P/S (TTM)4.41x

P/B1.78x

EV/EBITDA (TTM)19.59x

FCF yield (TTM)3.85%

PEG (TTM, GAAP)—

Context

P/E, own 5-year average37.18x

P/E, sector median29.65x*

Price at 5-year median P/E$58.05*

Indicated dividend yield0.24%

Forward — analyst consensus

Forward P/E (FY2026)21.43x*

Forward P/E (FY2027)19.46x

Forward PEG2.11*

Consensus EPS FY2026 (15 analysts)$5.35

EPS growth (FY2026→FY2027)10.14%

Revenue growth (FY2026)-0.18%

Street view

Price target (mean)$121.07*

Target upside5.59%

Ratings (buy / hold / sell)6 / 11 / 0

FY2026 EPS revisions, 30d (up / down)1 / 0

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 5 Apr 2026, filed 12 May 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR -9.27%10Y CAGR +7%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$114.66

Cash & equivalents$860.32M

Total debt$3.21B

Shares outstanding111.63M

Result

DCF price per share$12.50

Current price$114.66

Margin of safety-89.10%

PV of years 1–10$2.14B

PV of terminal value$1.61B

Equity value$1.40B

Market-implied growth+8.91%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$447.02M	$405.58M	$367.98M	$333.87M	$302.92M	$274.84M	$249.36M	$226.25M	$205.27M	$186.24M	$3.47B
PV	$413.91M	$347.72M	$292.12M	$245.40M	$206.16M	$173.20M	$145.50M	$122.23M	$102.69M	$86.27M	$1.61B

period to 5 Apr 2026, filed 12 May 2026, close 7 Aug 2026